sw-bic-213
Vaccineexperimental
Clinical trial activity
3 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
2
Phase 3
3
Phase 4
0
Earliest trial started Oct 19, 2022 (NCT05686161)
Timeline
Indications
Studied for
Mechanism of action
- SARS-CoV-2Immunity, active
SARS-CoV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT05911087 | Phase 2/Phase 3 (Phase 3) | Jun 20, 2023 | Government of Cambodia, Stemirna Therapeutics |
| NCT05580159 | Phase 3 | Oct 31, 2022 | Government of Cambodia, Stemirna Therapeutics |
| NCT05686161 | Phase 3 | Oct 19, 2022 | Government of Cambodia, Stemirna Therapeutics |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Government of Cambodia | Government | 3 | 0 | 1 | 2022 |
| Stemirna Therapeutics | For profit | 3 | 3 | 1 | 2022 |
2 organizations
Page 1 / 1